Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
10 min read
Hereditary sensory and autonomic neuropathy type 3 Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
7 August 2026
2026 Hereditary sensory and autonomic neuropathy type 3 strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built.
Latest Hotspot
10 min read
Hereditary sensory and autonomic neuropathy type 1 Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
7 August 2026
2026 Hereditary sensory and autonomic neuropathy type 1 strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built.
Latest Hotspot
10 min read
Spastic paraplegia type 2 Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
7 August 2026
2026 Spastic paraplegia type 2 strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Hereditary spastic paraplegia type 5A Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
7 August 2026
2026 Hereditary spastic paraplegia type 5A strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap.
Latest Hotspot
10 min read
Primary coenzyme Q10 deficiency type 4 Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
7 August 2026
2026 Primary coenzyme Q10 deficiency type 4 strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap.
Latest Hotspot
10 min read
Mitochondrial membrane protein-associated neurodegeneration Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
7 August 2026
2026 Mitochondrial membrane protein-associated neurodegeneration strategy covering epidemiology, unmet need, target biology, clinical competition and deal.
Latest Hotspot
10 min read
Leber hereditary optic neuropathy plus syndrome Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
7 August 2026
2026 Leber hereditary optic neuropathy plus syndrome strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with.
Latest Hotspot
10 min read
Maternally inherited diabetes and deafness Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
7 August 2026
2026 Maternally inherited diabetes and deafness strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with.
Latest Hotspot
10 min read
Riboflavin transporter deficiency Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
7 August 2026
2026 Riboflavin transporter deficiency strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP.
Latest Hotspot
10 min read
Giant axonal neuropathy Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
7 August 2026
2026 Giant axonal neuropathy strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
FOXG1 syndrome Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
7 August 2026
Explore the 2026 FOXG1 syndrome indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
10 min read
Woodhouse-Sakati neurologic syndrome Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
7 August 2026
2026 Woodhouse-Sakati neurologic syndrome strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap.